ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0JQ2 Kala Pharmaceuticals Inc

15.40
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0006.07M6.36M17.05M4.18M230k
Operating Income -32.67M-39.88M-64.72M-88.22M-96.23M-130.25M-81.71M-39.66M
Pre Tax Income -33.17M-42.21M-66.74M-94.35M-104.33M-142.61M-44.82M-42.2M
Net Income -33.17M-42.21M-66.74M-94.35M-104.33M-142.61M-44.82M-42.2M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -5.39-1.72-1.971-2.615-1.771-2.177-26.258-15.67
EBIT -32.67M-39.88M-65.11M-88.22M-96.23M-128.93M-35.64M-39.1M
EBITDA -32.37M-39.59M-64.37M-87.38M-95.32M-129.31M-81.29M-39.42M